Skip to main content
OpenTrials
Completed

NCT Number: NCT06120777

Clinical Validation for SpO2 Function of Masimo INVSENSOR00069

Assess the accuracy of INVSENSOR00069's peripheral oxygen saturation (SpO2) against contemporaneous measurement from arterial blood gas (ABG) analysis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Masimo Corporation

Irvine, California, 92618, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Influenced by study design:

  • Subject is 18 to 50 years of age.
  • Subject weighs a minimum of 110 lbs.
  • Hemoglobin value ≥ 11 g/dL.
  • Baseline heart rate ≥ 45 bpm and ≤ 90 bpm.
  • Systolic blood pressure ≤ 140 mmHg and ≥ 90 mmHg and diastolic blood pressure ≤ 90 mmHg and ≥ 50 mmHg. If systolic blood pressure is lower than 100 mmHg and/or diastolic blood pressure is lower than 60 mmHg, subject passes an orthostatic blood pressure test.
  • CO value ≤ 3.0% FCOHb.
  • Subject is comfortable to read and communicate in English*. *This is to ensure the subject can provide informed consent (as study materials are currently available in English only) and can comply with study procedures.

Exclusion criteria

Influenced by device warning labels:

  • Subjects with a skin condition affecting the digits, where the sensor is applied, which would interfere with the path of light (e.g., psoriasis, vitiligo, eczema, angioma, scar tissue, burn, fungal infection, substantial skin breakdown, etc.).
  • Subjects with nail polish or acrylic nails on the digits where sensor needs to be applied, who opt not to remove them.
  • Subject has hemoglobinopathies or synthesis disorders (e.g., thalassemia, sickle cell disease).
  • Subject has a peripheral vascular or vasospastic disease (e.g., Raynaud's disease).

Influenced by study design/environment:

  • Subjects who do not pass the health assessment for safe participation in the study procedures.
  • Difficulty inserting an intravenous line in the subject's hand or arm and/or an arterial line in the radial artery of the subject's wrist.

Treatment and study plan

INVSENSOR00069

Device

Noninvasive pulse oximeter

Primary outcomes

  1. SpO2 Accuracy of Masimo INVSENSOR00069

    Time frame: 1-3 hours

    The SpO2 accuracy of Masimo INVSENSOR00069 was determined by calculating the accuracy root mean-squared (Arms) difference between the measured values (SpO2) to the reference values (SaO2) in accordance with ISO-80601-2-61.

    Arms= √(∑(i=1 to n) ((SpO2_i-SaO2_i )^2 ))/n.

Sponsors and collaborators

Lead sponsor

Masimo Corporation

Industry

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Nov 7, 2023
Registry last updated
Nov 27, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.